Michelle D. McEvoy, on September 22, 2014.; The Petitioner seeks a Declaratory Statement from the Board in regard to whether it is within the scope of practice of a specially trained RN as defined in Section 464.003(20)(a)(b)(c), Florida Statutes, ...

 

DEPARTMENT OF HEALTH

Board of Nursing

NOTICE IS HEREBY GIVEN that the Board of Nursing has received the petition for declaratory statement from Michelle D. McEvoy, on September 22, 2014. The petition seeks the agency’s opinion as to the applicability of Section 464.003(20)(a)(b)(c), Florida Statutes, as it applies to the petitioner.

The Petitioner seeks a Declaratory Statement from the Board in regard to whether it is within the scope of practice of a specially trained RN as defined in Section 464.003(20)(a)(b)(c), Florida Statutes, to perform visually-guided sclerotherapy and administer the FDA-approved sclerosants of Sotradecol and Asclera under physicians orders and supervision. Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.

A copy of the Petition for Declaratory Statement may be obtained by contacting: Joe R. Baker, Jr., Executive Director, Board of Nursing, 4052 Bald Cypress Way, Bin #C02, Tallahassee, Florida 32399, [e-mail] or by telephone: [phone].